Hospices Civils De Lyon
Clinical trials sponsored by Hospices Civils De Lyon, explained in plain language.
-
New immunotherapy combo targets rare cancers left behind by progress
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs, domvanalimab and zimberelimab, in people with five types of advanced rare cancers (peritoneal mesothelioma, gestational trophoblastic tumor, anaplastic thyroid carcinoma, neuroendocrine tumors, and thymic carcinom…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Fertility drug trial for men with no sperm pulled before it began
Disease control TerminatedThis study aimed to see if the drug clomiphene citrate could help men with a condition called non-obstructive azoospermia, where the body produces little to no sperm. The plan was to give the drug or a placebo for nine months, then check if sperm could be found in the semen or th…
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New injection schedule may boost vision in diabetic eye disease
Disease control OngoingThis phase 2 study tests a new treatment plan for diabetic macular edema, a condition that causes vision loss. Instead of waiting for severe swelling, patients receive two dexamethasone implants 12 weeks apart, then additional injections only as needed. The goal is to improve vis…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Exercise and diet program aims to keep seniors on their feet
Prevention OngoingThis study looks at whether a program of supervised exercise and nutrition advice can prevent older adults from losing their ability to move around. It includes 530 people aged 80 or older who are at risk of mobility problems. Participants get a personalized exercise plan and die…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 26, 2026 14:34 UTC
-
35,000 asthma patients under the microscope: Real-World dupilumab use revealed
Knowledge-focused OngoingThis study looks at how dupilumab, a drug for severe asthma, is actually used by patients in France. Researchers will analyze health records of about 35,000 people to describe their characteristics, healthcare costs, and steroid use before and after starting the drug. The goal is…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New computer model aims to predict fractures in rare bone disorder patients
Knowledge-focused OngoingThis study is testing whether a computer tool called MEKANOS can better predict the risk of hip fractures in people with Fibrous Dysplasia or McCune-Albright Syndrome. Researchers will take CT scans of the femur and use the tool to calculate bone strength. The goal is to improve …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
French hospital digs into past TB cases to improve Kids' care
Knowledge-focused OngoingThis study looks back at the medical records of 150 children treated for tuberculosis at a French hospital. The goal is to see how many were cured, how many had problems, and why some treatments failed. By understanding these patterns, doctors hope to improve care for children wi…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to predict sudden death in severe epilepsy
Knowledge-focused OngoingThis study looks at how repeated seizures affect breathing and heart function in people with Dravet syndrome, a severe form of epilepsy. Researchers will monitor 92 children and adults for 24-48 hours using video, brain wave, heart, and breathing recordings. The goal is to find c…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Peer support program aims to curb burnout in medical residents
Knowledge-focused OngoingThis study tests whether having peer supporters trained in Mental Health First Aid (MHFA) can improve the mental well-being of first-year medical residents. About 520 residents in Lyon will be followed for a year, comparing those exposed to trained peers with those who are not. T…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Blood tests could reveal who benefits from immunotherapy
Knowledge-focused OngoingThis study looks at how well immunotherapy works in people with advanced lung or head and neck cancers. Researchers will take blood samples before and after treatment to measure how the body clears the drug and how tumor cells in the blood change. The goal is to find markers that…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:10 UTC